Effects of Real-time Continuous Glucose Monitoring System on Hospital-to-home Transitional Blood Glucose Control

Recruiting now · Not applicable

Conditions studied: Diabetes Mellitus, Type 2

In brief

Glucose monitoring is an important part of self-management for patients with diabetes. The results of glucose monitoring not only help to assess the degree of glucose metabolism disorders in patients, but also help physicians to make clinical decisions and guide patients in self-management. Despite extensive efforts and advances in diabetes management during hospitalization, glucose control after patients is discharged home remains a challenge. This trial aims to explore the effect of real-time continuous glucose monitoring (RT-CGM) system compared to self-monitoring of blood glucose (SMBG) group on glucose and self-efficacy of type 2 diabetes patients treated with insulin after discharge from the hospital.

Key facts

Study ID

NCT06591286

Run by

Shanghai 6th People's Hospital

People needed

150

Starts

2024-10-25

Expected to finish

2027-09-30

Last updated by the study team

2024-11-29

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 18 years old ≤ age ≤ 80 years old.
• Type 2 diabetes admitted to Department of Endocrinology and Metabolism.
• 8% ≤ HbA1c ≤ 12% in the last 1 month.
• Insulin therapy within 1 month of planned discharge from hospital.
• Frequency of self-monitoring of blood glucose <4 times per week and no use of real-time continuous glucose monitoring system in the 3 months prior to hospitalisation.
• Willing and able to provide written informed consent and comply with the requirements of this study.

You may not qualify if…

• Oral steroid hormone therapy.
• Patients with acute complications of diabetes (including Diabetic ketoacidosis, hyperglycemia and hyperosmolality, Lactic acidosis)
• Patients with severe liver disease (alanine aminotransferase or glutamine aminotransferase exceeding more than three times the upper limit of normal).
• Patients with severe kidney injury or end-stage renal disease (eGFR < 30 mL/min/1.73 m2).
• Participants were unable to tolerate tape adhesive around sensor placement area, or with medically documented allergy towards the adhesive (glue) of plasters, or with serious skin diseases (e.g. psoriasis vulgaris, bacterial skin diseases) around sensor placement area.
• Mental condition rendering the subject unable to understand the nature, scope, and possible consequences of the study.
• Pregnant, breastfeeding, women of childbearing age who are unwilling to use contraception during the study period.

Where it is running

• Shanghai 6th People's Hospital — Shanghai, Shanghai Municipality, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.